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Introduction
Gold nanoparticles (GNPs) increase dose deposition when localised
to the tumour
Studies have demonstrated this in cell and animal studies through
an increase in survival rates 1,2
Monte Carlo studies have modelled physical dose enhancement 3
Many biological studies have been performed demonstrating dose
enhancement, however these do not quantify physical dose
enhancement
The present study demonstrates a novel method to quantify
physical dose enhancement using Gafchromic films and a custom
made phantom
Aim
To quantify the physical dose enhancement of GNPs through
Gafchromic film measurements
Method
The phantom (figure 1) contained slits at 1 mm intervals to hold film
sheets at various depths
Phantom was comprised of PMMA as this is commonly used in
proton therapy for its water equivalence
The phantom was positioned within the width of the Bragg peak to
allow for a high resolution depth dose plot
EBT3 Gafchromic films (Ashland, USA) were used for the
measurements
Solid water slabs (Gammex, Middleton, WI) were used to create
sufficient build up (29.1 cm) in front of the phantom to tune Bragg
peak position to within the phantom (figure 2)
Measurements were carried out at the Trento proton therapy centre
using a 226 MeV proton beam
Measurements were taken for both water and water + GNP solution
Concentrations of GNPs used were 5.5 and 1.1 mgAu/ml
Each depth was irradiated with 20 MU corresponding to a dose
range of 6-37 cGy
Films were calibrated covering a dose range from 0-250 cGy, using a
clinically used procedure
Films were scanned after 24 hours using an EPSON desktop scanner
Depth dose plots were used to determine the level of dose
enhancement
Dose enhancement is defined as the ratio of the dose with and
without GNPs for the depth being considered
Figure 1: Custom made film
phantom containing GNPs and a
Gafchromic film. Phantom allows
for measurements to be taken at
1 mm intervals
Results
Considering the depth dose plot (figure 3) it can be seen that there is
an increase in dose deposition with the introduction of GNPs
Dose deposition increases by 26%±0.53 with 1.1 mg/ml and
21%±0.53 with 5.5 mg/ml
It was expected that dose enhancement would increase with
concentration, whereas these results showed a higher enhancement
with the lower concentration
Other studies have shown Gafchromic films to be prone to quenching
effects which could have had a greater effect at higher concentrations,
leading to the lower enhancement observed 4
 As well as dose enhancement a 2.2 mm longitudinal shift of the distal
edge was shown with 5.5 mg/ml of GNPs
 Shape changes must be taken into account to ensure the entire
tumour is irradiated and there are no under dosed regions
Conclusions
 GNP concentration of 1.1 mg/ml showed a higher dose enhancement
of 26% compared to 21% for 1.1 mg/ml
 Longitudinal shift was shown only with 5.5 mg/ml and was found to
be 2.2 mm
 Effects of GNP concentrations were shown through measurement of
physical dose enhancement
 Reasons for not having an increase in dose deposition with increasing
concentration could be due to quenching effects
 Changes to the Bragg peak shape due to the presence of GNPs needs
to be accounted for in future studies to ensure full tumour coverage
 These results demonstrate physical dose enhancement alone
 Cellular studies should be performed to determine how physical dose
enhancement by GNPs translates to biological systems
Future work
 Investigate the effects of GNP enhancement on treatment plans,
assessing any changes that need to be made
 Parallel cell studies to determine biological effect resulting from
physical dose enhancement
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Figure 2:
Experimental setup
with solid water
equivalent to 29.1
cm of water followed
by the film phantom
with inner
dimensions of 4.1
cm. Phantom was
filled with either
water or a water +
GNP solution of a
known concentration
Figure 3: Depth dose
plot normalized to
peak water dose to
show the level of
enhancement with
GNP concentrations of
1.1 and 5.5 mg/ml.
Errors correspond to
two standard
deviations.
Figure 4: Depth dose
plot normalized to
peak dose of the
material to show the
changes caused to the
shape of the Bragg
peak with GNP
concentrations of 1.1
and 5.5 mg/ml. Errors
correspond to two
standard deviations.
